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a  b  s  t  r  a  c  t
Paratuberculosis  is  a  chronic  intestinal  disease  of ruminant  animals  caused  by Mycobacterium  avium
subsp.  paratuberculosis  (MAP).  A hallmark  of paratuberculosis  is  a transition  from  a  cell-mediated  Th1  type
response  to  a humoral  Th2 response  with  the  progression  of  disease  from  a subclinical  to clinical  state.
The  objective  of this  study  was  to investigate  the  expression  of two crucial  molecules  in T cell  function,
ZAP-70  (zeta-chain-associated  protein  of  70 kDa)  and  CTLA-4  (cytotoxic  T-lymphocyte  antigen-4),  in
cows  naturally  infected  with  MAP.  Peripheral  blood  mononuclear  cells  (PBMCs)  isolated  from  control
non-infected  cows  (n =  5),  and  cows  in  subclinical  (n =  6)  and  clinical  stages  of  paratuberculosis  (n =  6)
were  cultured  alone  (medium  only),  and  with  concanavalin  A,  and  a whole  cell  sonicate  of MAP  for 24,  72
and 144  h  to  measure  the  dynamic  changes  of  ZAP-70  and  CTLA-4  expression  on  CD4,  CD8,  and  gamma
delta  () T cells.  Flow  cytometry  was  also  performed  to measure  ZAP-70  phosphorylation  to  examine
proximal  T  cell  receptor  signaling  in  animals  of  different  disease  status.  The  surface  expression  of CTLA-
4  was  increased  in  animals  in  subclinical  stage  of infection  while  levels  of  ZAP-70  were  decreased  in
CD4+  T cells  of  both  subclinical  and  clinical  animals,  indicating  a change  in T cell  phenotype  with  disease
state.  Interestingly,  proximal  T cell receptor  signaling  was  not  altered  in  infected  animals.  This  study
demonstrated  changes  in  crucial  signaling  molecules  in  animals  infected  with  MAP,  thereby  elucidating
T  cell  alterations  associated  with  disease  progression.
Published by Elsevier  B.V.
1. Introduction
Paratuberculosis, also called Johne’s disease, is a disease of rumi-
nant animals caused by the bacterium Mycobacterium avium subsp.
paratuberculosis (MAP). Paratuberculosis is a chronic enteric dis-
ease with high economic impact in US dairy cattle, where it can
cause decreased milk production, lead to early culling of animals,
and reduce fertility rates (Lombard, 2011). The disease is primarily
subclinical, and clinical signs such as diarrhea and weight loss can
take from 2 to 5 years to manifest (Stabel, 1998). The disease has
worldwide distribution in most ruminant species, and prevalence
of paratuberculosis at the dairy herd level in the US is estimated to
be 91.1% (Lombard et al., 2013).
∗ Corresponding author. Tel.: +1 515 337 7304; fax: +1 515 337 7428.
E-mail address: judy.stabel@ars.usda.gov (J.R. Stabel).
1 Present address: Department of Veterinary Population Medicine, University of
Minnesota, St. Paul, MN,  United States.
Infection of ruminant animals occurs primarily via exposure to
contaminated feces or ingestion of colostrum/milk from infected
dams (Stabel, 1998). Upon infection, MAP  passes through the M
cells and epithelial cells in the small intestine where it is phago-
cytized by macrophages within the submucosa (Bannantine and
Bermudez, 2013). Initially, animals control infection with a Th1
response predominated by the secretion of cytokines such as IFN-
 that activate macrophages to kill the intracellular bacterium
(Sweeney, 2011). As disease progresses and clinical manifesta-
tions begin to occur, there is a shift from a cell-mediated Th1 to
a non-protective Th2 response characterized by antibody titers to
MAP. The molecular mechanisms underlying this transition are
poorly understood (Stabel, 2006). Some animals that demonstrate
clinical signs of disease may  have both Th1 and Th2-mediated
immune responses, whereas other clinical animals seem to lose
Th1-mediated immunity. Previous research has also found that
cells isolated from animals with clinical disease neither secrete IFN-
 when stimulated with MAP  antigen, nor proliferate or respond
to T cell mitogens such as concanavalin A (Weiss et al., 2006;
Begg et al., 2011). This suggests that there are other mechanisms
http://dx.doi.org/10.1016/j.vetimm.2015.06.017
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involved in T cell function during the progression of disease other
than simply the shift to a Th2 response, and these may  include the
induction of tolerance and anergy/hypofunction of T cells.
ZAP-70 (zeta-chain associated protein of 70 kDa) and CTLA-4
(cytotoxic T-lymphocyte antigen-4) are two critical components of
the T cell that are involved in modulation of host immune responses
(Wang et al., 2010; Walker and Sansom, 2011). Upon engagement of
the T cell receptor with an antigen presented by an MHC  molecule
of an antigen presenting cell, ZAP-70 is directed to ITAMS (immuno-
receptor tyrosine-based activation motifs) of the zeta chain of the
CD3 receptor, after which it is activated by phosphorylation and
invokes downstream signaling molecules of the T cell leading to its
full activation (Wang et al., 2010). Depletion studies have demon-
strated that in the absence of ZAP-70 a functional immune synapse
cannot occur, resulting in retardation of cell activation with sub-
sequent impacts on ability of the cell to secrete cytokines or carry
out effector functions (Blanchard et al., 2002). In contrast, CTLA-4 is
regarded as a major negative regulator of T cell responses and its co-
ligation with the T cell receptor (TCR) can induce anergy (Schneider
et al., 2008). Its inhibitory function occurs by engagement of B7 lig-
ands (CD80/CD86) expressed on antigen presenting cells, resulting
in inhibition of cytokine production and T cell proliferation (Rudd
et al., 2009). These two molecules work together to either allow T
cell activation (ZAP-70) or to abrogate T cell responses (CTLA-4) in
the host.
The present study was designed to measure signaling molecules
of T cell activation, ZAP-70 and CTLA-4, through flow cytometry in
cows in different stages of paratuberculosis. Mechanisms of cellular
activation were further explored by quantifying the phosphory-
lation of ZAP-70 following activation of cells to determine if the
signaling cascade was compromised.
2. Methods
2.1. Animals
Holstein dairy cows averaging 6 years of age were used in this
study and placed in three groups based upon stage of disease.
Treatment groups consisted of noninfected healthy cows (n = 5),
cows naturally infected with M.  avium subsp. paratuberculosis but
asymptomatic (subclinical; n = 6), and cows with clinical signs of
paratuberculosis (clinical; n = 6). Animals were classified as sub-
clinical or clinical based upon results from IFN- release assay
(Prionics, La Vista, NE) using a whole cell sonicate of MAP  (MPS) as
the antigen, serum antibody (Herdcheck, IDEXX, Westbrook, ME)
and fecal culture. By definition, clinical cows were shedding more
than 100 CFU per g of feces and presented with weight loss and
intermittent diarrhea. Clinical cows had higher serum antibody
titers than subclinically infected cows (Sample/Positive ratio = 2.12
vs 0.11, respectively), but lower IFN- responses (Abs450nm = 0.36
vs 0.98, respectively). Subclinically infected cows were shedding
less than 10 CFU/g of feces and did not present clinical signs of
disease. Noninfected control cows were characterized by repeated
negative fecal culture performed semi-annually over a 3–5-year
period as well as negative results in serum antibody and IFN-
release assay. All animals were housed in American Association
for Accreditation of Laboratory Animal Care-accredited facilities
and all animal related procedures were approved by the IACUC
(National Animal Disease Center, Ames, IA). Cows infected with
MAP  were housed separately from healthy control cows to prevent
cross-contamination between groups.
2.2. Blood collection, culture conditions, and sample collection
Blood was collected from the jugular vein in 2X acid citrate-
dextrose solution (1:10) and used for isolation of peripheral
blood mononuclear cells (PBMCs) from the buffy coat as pre-
viously described (Khalifeh and Stabel, 2013). These cells were
resuspended to 2 × 106 cells/ml in complete RPMI-1640 medium
(Gibco, Carlsbad, CA) supplemented with 100 units/mL of peni-
cillin, 100 g/mL of streptomycin, and 0.25 g/mL of Fungizone®
(Gibco). Cell culture was  performed in 6-well flat-bottomed plates
at 39 ◦C in 5% CO2 in a humidified atmosphere. In vitro treatments
consisted of no stimulation (NS; medium only), concanavalin A
(ConA) (10 g/ml; Sigma, St. Luis, MO), and a whole-cell sonicate
of MAP  (MPS; 10 g/ml) prepared as previously described (Stabel
et al., 2011). Plates were incubated for 24, 72 and 144 h and cells
were harvested for flow cytometric analyses. During the last 5 h of
incubation a cocktail of 10 g/ml brefeldin A (Sigma), 1 g/ml ion-
omycin (Sigma) and 50 ng/ml PMA  (Sigma) was  added to culture
wells to enable intracellular measurement of IFN-.
2.3. Flow cytometric measurement of ZAP, pZAP-70, CTLA-4, and
IFN-
Cells were gently removed from culture plates by pipetting and
resuspending cultures in phosphate buffered saline (PBS). Cells
were added at a concentration of 1 × 106 cells per well in a 96-
well round bottom plate (Corning, Corning, NY), followed by 50 l
of a cocktail of primary antibodies to T cell surface markers CD4,
CD8, gamma  delta T cell receptor ( TCR) (WSU Monoclonal Anti-
body Center, Pullman, WA)  and CTLA-4 (Ancell, Stillwater, MN)
(Table 1). After a 15 min  incubation at room temperature (RT),
plates were centrifuged for 2 min  at 400 × g, the supernatant was
decanted, and 50 l of a secondary antibody cocktail was added,
which included PE-Cy7 anti-mouse IgM (5 l/ml; Southern Biotech,
Birmingham, AL), APC Cy7 anti-mouse IgG2b (7 l/ml; Southern
Biotech), and Alexa Fluor 350 anti-mouse IgG1 (25 l/ml; Life Tech-
nologies, Carlsbad, CA). After incubation for 15 min  at RT, plates
were centrifuged as described above then fixed and permeabilized
following manufacturer’s instructions with the Cytofix/Cytoperm
solution (BD Biosciences San Jose, CA). Cells were washed twice
with Perm/Wash buffer (BD Biosciences), followed by intracellular
staining for 30 min  at 4 ◦C for the molecules ZAP-70, phosphory-
lated ZAP-70 (pZAP-70), and IFN-. After another two washes with
Perm/Wash buffer (BD Biosciences) cells were resuspended in PBS
with 0.4% sodium azide for flow cytometric analysis. Samples were
evaluated using 10,000 events per sample, using a FACScan flow
cytometer (CellQuest software; Becton Dickinson). Analyses were
conducted by gating on live cells based upon forward and side
scatter characteristics (FlowJo; Tree Star). Due to the low level of
live cells in the ConA treatment at 144 h culture this treatment was
not considered for further analysis.
Table 1
Primary antibodies used in study.




CD4 IgM 10 CATC83B PE-Cy7
CD8 IgG1 10 CACT80C Alexa 350
CD8 IgG2a 20 MCA837 Alexa 350
  TCR IgG2b 10 GB21A APC Cy7
CTLA-4a IgG1 8 ANC152.2/8H5 PerCp
ZAP-70a IgG1 10 1E7.2 Pacific Blue
IFN-a IgG1 20 MCA1783PE PE
pZAP-70a Rabbit
polyclonal
10 Polyclonal to Y319 Alexa488
a Refers to antibodies that were directly conjugated, CTLA-4 to PerCp; ZAP-70 to
Pacific Blue, IFN- to PE, and pZAP-70 to Alexa Fluor® 488. Surface marker antibodies
were diluted in PBS with 0.4% sodium azide whereas intracellular marker antibodies
(ZAP-70, pZAP-70, IFN-) were diluted in BD Perm Wash buffer.
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2.4. Phospho flow cytometric analysis of pZAP-70
To measure ZAP-70 phosphorylation during T cell activation, the
technique of phospho flow cytometry was used following a mod-
ified protocol (Haas et al., 2008). Isolated PBMCs were plated at
2 × 106/ml  in 96-well round bottom plates in RPMI-1640 medium
(Life Technologies) and allowed to rest for 1 h at 39 ◦C in 5% CO2. No
fetal bovine serum was present in the medium in order to reduce
baseline ZAP-70 phosphorylation. Antigen-specific T cell activation
was performed with a whole-cell sonicate of MAP  (MPS; 10 g/ml).
Two positive controls, anti-CD3 (10 g/ml; MM1A; WSU  Mono-
clonal Antibody Center) and 11 mM hydrogen peroxide (H202) were
included to assess assay performance and non-specific responses
of cells to stimulation. After addition of different stimulants, cells
were incubated for 15 min  at 39 ◦C in 5% CO2 in a humidified atmo-
sphere, followed by fixation of the cells to halt phosphorylation
events with Cytofix/Cytoperm solution (BD Biosciences). After cells
were fixed and permeabilized, cell staining followed the proto-
col of cultured cells for staining of pZAP-70 and ZAP-70 within
CD4, CD8 and  TCR T cells (Table 1). A substitution of CD8 clone
MCA837 (Serotec Raleigh, NC) was made as the clone CACT80C
(WSU Monoclonal Antibody Center) does not stain cells that have
been previously fixed. A prior time trial determined that maximum
ZAP-70 phosphorylation was achieved at 15 min  (data not shown),
therefore, this was the time selected for cell activation used in the
experiments.
2.5. Tissue immunofluorescent staining for ZAP-70
Immunofluorescence staining was performed on 5 M frozen
ileum sections from non-infected (n = 2), subclinical (n = 5) and clin-
ical (n = 5) animals. Briefly, after fixation in acetone:ethanol (1:1)
solution, tissue sections were blocked in 10% normal goat serum
(NGS) in PBS solution for 30 min  at RT and labeled overnight at
4 ◦C with anti-ZAP-70 (1:1500; Invitrogen Carlsbad, CA) and anti-
CD4 (1:500; VMRD, Inc. Spokane, WA)  antibodies. After repeated
washing with PBS, the slides were incubated with Alexa Fluor
594 (1:800; Invitrogen) and Alexa Fluor 488 (1:800; Invitro-
gen) for 1 h at RT. Staining was examined using an E800 Eclipse
fluorescence microscope (Nikon, United Kingdom). Images were
analyzed (pixel intensity) using SPOT 4.7 Advanced Plus software
(SPOT Imaging Solutions, Diagnostic Instruments, Inc.). For overlay,
images were adjusted to the same output intensities and merged
into a composite image for 2 animals from each infection sta-
tus.
2.6. Statistical analysis
Statistical analysis was performed using the PROC Mixed func-
tion of SAS 9.02 (SAS Institute, Cary, NC). Data obtained from the
comparison between treatments, clinical status and day, for each
molecule in each cell type were analyzed using a mixed linear
model followed by Tukey’s range test. Results from 144 h cultures
were analyzed in a separate model because of omission of the ConA
treatment and higher variance within samples. Two-sided P < 0.05
values were considered significant.
3. Results
3.1. T cell expression of ZAP-70
After 24 h culture, ZAP-70 expression on CD4+ T cells was  sig-
nificantly (P < 0.05) lower for both subclinical and clinical cows
compared to noninfected controls, regardless of in vitro treatment.
Fig. 1. Expression of ZAP-70 on (A) CD4, (B) CD8, and (C) gd TCR T cells after culture
of  PBMCs isolated from control cows and cows naturally infected with Mycobac-
terium avium subsp. paratuberculosis. Cells were cultured with medium alone (NS),
concanavalin A (ConA), or a whole cell sonicate of MAP  (MPS) for 24 h. Data are
presented as percentage of ZAP-70+ T cells (mean ± SEM). Significant differences
between animal treatment groups are designated by different letters, a, b (P < 0.05).
A trend for reduced ZAP-70 expression was also true for CD8 and
 T cells from infected cattle, although differences were not sta-
tistically significant (Fig. 1). Extending PBMC culture times to 72
and 144 h resulted in an increase in the percentage of ZAP-70+ CD4
T cells from 50.8% to 62.7% and 78.8%, respectively for clinically
infected cows, reaching levels similar to noninfected animals by
144 h (Fig. 2a). Interestingly, an increase in ZAP-70 expression on
CD4 T cells was  noted for subclinical cows between 24 and 72 h but
no further increases were noted at 144 h, resulting in significantly
(P < 0.05) lower expression of ZAP-70 for this group. In contrast,
pZAP-70 trended toward higher expression on CD4 T cells at all
time points for noninfected control cows compared to the infected
groups (Fig. 2b). Further, differences in ZAP-70 or pZAP-70 expres-
sion were not observed for CD8+ and  TCR+ T cells regardless
of animal treatment group at extended culture times, although
patterns of lower pZAP-70 expression for infected cows paralleled
CD4+ T cells (data not shown).
3.2. Analysis of CTLA-4 and IFN- expression in T cells of 24, 72
and 144 h cultures
Surface expression of CTLA-4 was  measured in CD4, CD8, and 
T cell subsets at 24, 72 and 144 h time points. At 24 h, cows in the
subclinical group had a higher (P < 0.05) percentage of CD4+ T cells
expressing CTLA-4 for all in vitro treatments when compared to
control and clinical cows (Fig. 3A). This effect was also observed
in CD8+ T cells but was not statistically significant (Fig. 3B). In
contrast, surface expression of CTLA-4 was  negligible on T cells
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Fig. 2. Expression of ZAP-70 (A) and pZAP-70 (B) on CD4+ T cells after culture of
PBMCs isolated from control cows and cows naturally infected with Mycobacterium
avium subsp. paratuberculosis. Cells were cultured with a whole cell sonicate of
MAP  (MPS) for 24, 72, or 144 h. Data are presented as percentage of ZAP-70+ or
pZAP-70+ T cells (mean ± SEM). Significant differences between infection group are
designated by different letters, a, b (P < 0.05).
after 24 h of culture, regardless of in vitro treatment (Fig. 3C).
Differences noted in CTLA-4 expression on CD4+ T cells between
infection groups was also demonstrated in a representative flow
cytometry density plot, averaging 3.9, 22.4, and 12.8% for control,
subclinical and clinical cows, respectively (Fig. 4). Upon extending
culture times to 72 and 144 h, marginal differences were observed
between treatment groups with the number of CTLA-4+ CD4 T cells
decreasing from 24.1 to 12.5% between 24 and 72 h of culture for
subclinical cows (Fig. 5A). Upon stimulation of PBMC with MPS,
levels of intracellular IFN- did tend to be higher for infected cows
compared to controls over time (Fig. 5B), however, the high degree
of variability precluded any significance. Measurement of intracel-
lular IFN- in ConA-stimulated PBMC demonstrated an opposite
trend with higher overall expression in control cows compared to
infected cows (data not shown).
Fig. 3. Expression of CTLA-4 on (A) CD4, (B) CD8, and (C) ı TCR T cells after culture of
PBMCs isolated from control cows and cows naturally infected with Mycobacterium
avium subsp. paratuberculosis (MAP). Cells were cultured with medium alone (NS),
concanavalin A (ConA), or a whole cell sonicate of MAP  (MPS) for 24 h. Data are
presented as percentage of ZAP-70+ T cells (mean ± SEM). Significant differences
between animal treatment groups are designated by different letters, a, b (P < 0.05).
3.3. Phospho flow cytometry and measurement of ZAP-70
phosphorylation
To address proximal T cell receptor signaling and T cell
activation, phospho flow cytometry was  performed to measure
phosphorylation of ZAP-70 following TCR (T cell receptor) engage-
ment. Hydrogen peroxide and anti-CD3 antibody were included
Fig. 4. Histogram demonstrating representative flow cytometric staining for surface expression of CTLA-4 on CD4+ T cells from a control cow (A), subclinical cow (B), and a
clinical  cow (C) after culture of PBMCs for 24 h with a whole cell sonicate of MAP  (MPS).
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Fig. 5. Expression of CTLA-4 (A) and IFN- (B) on CD4+ T cells after culture of PBMCs
isolated from control cows and cows naturally infected with Mycobacterium avium
subsp. paratuberculosis. Cells were cultured with a whole cell sonicate of MAP  (MPS)
for 24, 72, and 144 h. Data are presented as percentage of CTLA-4+ or IFN-+ T
cells  (mean ± SEM). Significant differences between animal treatment groups are
designated by letters, a, b (P < 0.05).
as positive controls to measure the activation capacity of the
cell in an antigen-independent manner, via non-receptor- and
receptor-mediated events. Within the CD4+, CD8+, and  TCR+
T cell subsets, treatment with H2O2 or anti-CD3 yielded significant
(P < 0.05) increases in pZAP-70 expression for all cows in relation
to the NS treatment (Fig. 6). In contrast, pZAP-70 expression in
T cells was not different between the MPS  and NS treatments,
regardless of animal infection status. However, a pattern of higher
(P < 0.05) pZAP-70 expression in CD4+ T cells from infected cows
was observed after in vitro treatment of cells with H202 (Fig. 6A).
This pattern of expression across treatment groups was repeated
after treatment of cells with either MPS  or anti-CD3, albeit at a
lower level. Additionally, a trend toward higher expression of pZAP-
70 in CD8+ T cells was observed for subclinical cows, regardless of
in vitro treatment (Fig. 6B), and in  TCR+ T cells to a lesser extent
(Fig. 6C).
3.4. Immunofluorescence analysis of ZAP-70 in ileum CD4+ T cells
To evaluate the presence of ZAP-70 at the site of infection in
a known target tissue, immunofluorescence was performed on
sections of ileum obtained from control, subclinical and clinical
cows at necropsy. Upon staining for ZAP-70, differences in stain-
ing intensity were observed between the control, subclinically and
clinically infected cows, averaging 38.9 ± 6.8, 15.2 ± 3.4, and 21 ± 3
pixel intensity, respectively. Interestingly, mean staining intensity
for CD4+ T cells in the ileum was also lower for infected cows
compared to control cows (22.3 ± 3.3 vs 53.8 ± 0.9). In tissue from
control cows, CD4+ T cells were found to be co-localized with ZAP-
70 throughout the entire section of ileum (Fig. 7). In contrast, ileal
tissue from clinical cows showed a marked reduction in the number
of CD4+ T cells expressing ZAP-70 (Fig. 7).
Fig. 6. Phopho flow analysis of pZAP-70 on (A) CD4, (B) CD8, and (C) ı TCR T cells
after stimulation of PBMCs isolated from control cows and cows naturally stimulated
with medium alone (NS), a whole cell sonicate of MAP  (MPS), anti-CD3 antibody,
and hydrogen peroxide (H2O2). Data are presented as percentage of pZAP-70+ T
cells (mean ± SEM). Significant differences between animal treatment groups are
designated by designated by different letters, a, b (P < 0.05).
4. Discussion
Studies on animals with paratuberculosis have provided evi-
dence suggesting that anergy or T cell hypofunction occurs in the
advanced stages of disease. Lymphocytes isolated from the ileum
of infected cows did not proliferate after incubation with MAP  anti-
gen, demonstrating a hyporesponsive state of these cells correlating
with anergy (Weiss et al., 2006). Similarly, investigation of the cel-
lular immune response to MAP  in naturally and experimentally
infected sheep yielded attenuated responses in animals in more
advanced stages of disease (Begg et al., 2011). These observations
are part of an immune shift that occurs in paratuberculosis that is
marked by a loss of cell-mediated immunity corresponding with
lower IFN- and increased IL-10 levels and a subsequent rise in
humoral immunity (Stabel, 2006). In paratuberculosis there are a
limited number of studies that have addressed potential alterations
within T cells and the events leading to clinical disease. Yet this
information is critical to providing a better understanding of the
disease as well as the possibility of more targeted approaches for
vaccine and therapeutic development.
In the present study, both flow cytometric and immunofluores-
cent staining demonstrated that infected cows had fewer ZAP-70+
T cells, particularly within the CD4+ T cell subset. Interestingly,
regardless of treatment, clinical and subclinical animals had fewer
ZAP-70 positive cells at 24 h. This may indicate a broad change
in these cells which cannot be reversed by strong T cell stimu-
lation, as fewer positive cells were also observed after treatment
with the T cell mitogen concanavalin A. It has been shown that
patients with advanced forms of leprosy have significantly less
20 F.L. Leite et al. / Veterinary Immunology and Immunopathology 167 (2015) 15–21
Fig. 7. Immunofluorescent staining of ileal sections from a control cow (top panel) and a cow clinically infected with Mycobacterium avium subsp. paratuberculosis (bottom
panel)  for CD4+ T cells (A), ZAP-70+ cells (B), and merged images of CD4 and ZAP-70 stains (C). Dual positive cells are indicated by yellow color in merged images.
pZAP-70 and ZAP-70 present in their T cells (Kumar et al., 2011).
Similar to paratuberculosis, patients in the early stages of infection
(tuberculoid leprosy) possess a cell-mediated immunity (CMI) that
is considered to be effective in controlling disease. This later tran-
sitions to more severe lepromatous leprosy phase in which clinical
signs of disease become evident and T cell hypofunction has been
observed (Walker and Lockwood, 2006). Considering the impor-
tance of ZAP-70 in T cell signaling, it would be expected that the T
cells identified as being ZAP-70 negative have a decreased poten-
tial for activation and effector function, potentially being rendered
anergic.
There was an increase in the relative number of CTLA-4 +
CD4 T cells in animals with subclinical paratuberculosis and dif-
ferences in expression between subclinical and clinical animals
as well as control non-infected animals were more prominent
within the CD4+ population. Several studies on the expres-
sion of CTLA-4 in ruminants have focused on  T cells with
inconsistent observations (Hanrahan et al., 1997; Blumerman
et al., 2007; Fikri et al., 2000). However, these studies did not
measure CTLA-4 on the surface of cells as performed in this
study, rather mRNA levels were measured; measurement of
CTLA-4 on the cellular surface is important since it is tightly regu-
lated due to its impacts on T cell function (Valk et al., 2008).
A decrease in CTLA-4 expression over time has previously been
observed in the different T cell subsets in mice and humans, demon-
strating that upon T cell activation the maximal surface expression
of CTLA-4 occurs following 48–72 h, followed by reduced expres-
sion with longer incubation periods (Walunas et al., 1994; Wang
et al., 2001). In this study, maximal expression was found at 24 h,
possibly due to a difference in host species and/or stimulation con-
ditions.
Perhaps it is not a coincidence that the CD4+ T cells were the
subset with the highest CTLA-4 expression. This is the same pop-
ulation that would be expected to play a bigger role in directing
a Th1 type response through macrophage activation. MAP may
induce a higher expression of CTLA-4 in T cells of infected ani-
mals as an evasion strategy from the immune system to promote
chronic infection. Interestingly, patients with leprosy generated
similar patterns of CTLA-4 expression whereby patients with tuber-
culoid leprosy expressed significantly more CTLA-4 compared to
lepromatous patients (Palermo et al., 2012). As suggested in that
study and in corroboration with data from the present study, CTLA-
4 expression may  be involved in the induction of T cell hypofunction
during early and mid-stages of infection, whereas it is likely other
molecules could be involved in the maintenance of an anergic T cell
state in the later stages of chronic infection. Programmed death-1, a
cell surface molecule that regulates adaptive immune response and
is related to T cell exhaustion, may  be one candidate, as it induces
a state that is progressive, with dysfunction worsening overtime
(Wherry, 2011).
Also pertinent to paratuberculosis infection are other roles that
CTLA-4 has been demonstrated to have in Th1 cells. These include
T cell differentiation and migration to sites of inflammation and
antigenic challenge (Oosterwegel et al., 1999; Knieke et al., 2009).
This may  provide an explanation of how animals in the subclini-
cal stage can control infection if T cells expressing high levels of
CTLA-4 are efficiently migrating to target sites of infection. In addi-
tion, cells that express CTLA-4 have been shown to have extrinsic
functions causing downregulation in other cells. This includes the
induction of indoleamine 2,3-dioxygenase (IDO) activity in APCs,
which leads to tryptophan catabolism that can inhibit other T cells
from proliferating (Walker and Sansom, 2011). This may  also be
an immune alteration caused by the increased CTLA-4 + T cells
in animals infected with MAP  as increased IDO activity has been
described in animals with paratuberculosis (Plain et al., 2011).
The lack of changes in proximal T cell receptor signaling as
measured by TCR activation and ZAP-70 phosphorylation between
infected and control animals in this study is not necessarily surpris-
ing. Phospho flow cytometry was used to compare T cell receptor
signaling among CD4+ T cells, and found that T cell activation by
anti-CD3 antibody induced a higher magnitude of ZAP-70 phos-
phorylation in Tregs compared to non-Treg CD4+ T cells (Hanschen
et al., 2012). Also, it was  found that antigen-specific TCR stim-
ulation did not significantly activate these signaling pathways,
similar to what is reported here. An elevated number of Treg cells
in PBMCs of animals infected with MAP  have been reported and
may  explain the lack of alteration in proximal T cell signaling in
this study, with the clinical group yielding the highest phosphory-
lated ZAP-70 response in CD4+ T cells following anti-CD3 activation
(Coussens et al., 2012). A subject for future investigation is if MAP
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has the ability to directly inhibit ZAP-70 phosphorylation as has
been described in studies with M.  tuberculosis. It has been shown
that pre-incubation of T cells with M.  tuberculosis mannosylated
lipoarabinomannan (Man-LAM) inhibits ZAP-70 phosphorylation, a
mechanism likely due to insertion of Man-LAM into the membrane
of target T cells (Mahon et al., 2012).
5. Conclusion
This study investigated crucial molecules involved in T cell func-
tion in the context of paratuberculosis. Very few studies have
addressed T cell function in paratuberculosis, especially T cell
signaling events. Surprisingly, findings from this study correlate
very well with findings from studies with M.  leprae,  suggesting
the etiological agents of both diseases share similar mechanisms
of immune evasion to cause chronic infection. This study for the
first time discovered alterations in two crucial signaling molecules
of the T cell in animals infected with MAP, shedding light into
immune alterations that occur and possible triggers that lead to
clinical paratuberculosis.
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